XML 20 R4.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues $ 1,297 $ 183 $ 1,608
Cost of revenues 17,571 3,681 3,270
Gross loss (16,274) (3,498) (1,662)
Operating expenses:      
Research and development expenses, net 45,432 49,460 82,662
Selling, general and administrative expenses 19,988 26,171 35,568
Other expenses 24,716 0 0
Total operating expenses 90,136 75,631 118,230
Operating loss (106,410) (79,129) (119,892)
Income (Loss) from warrants remeasurement 37,953 (22,750) 396
Financial income (expenses), net 10,658 (7,812) 3,928
Net loss before income tax (57,799) (109,691) (115,568)
Taxes on income (tax benefit) (1,992) 2,063 (1,360)
Net loss (55,807) (111,754) (114,208)
Net comprehensive loss $ (55,807) $ (111,754) $ (114,208)
Weighted average number of ordinary shares used in computing basic net loss per share (in shares) 32,140,321 15,933,291 10,087,691
Weighted average number of ordinary shares used in computing diluted net loss per share (in shares) 32,140,321 15,933,291 10,087,691
Class A Ordinary Shares      
Operating expenses:      
Basic net loss per share (in USD per share) $ (1.74) $ (7.01) $ (11.32)
Diluted net loss per share (in USD per share) $ (1.74) $ (7.01) $ (11.32)
Weighted average number of ordinary shares used in computing basic net loss per share (in shares) 32,140,321 15,933,291 10,087,691
Weighted average number of ordinary shares used in computing diluted net loss per share (in shares) 32,140,321 15,933,291 10,087,691